Solx Lands $3,250,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3d8c46a9-580b-4c5a-9d12-f3366858b77a&Preview=1 -
Date
1/20/2012 -
Company Name
Solx -
Mailing Address
230 Second Ave. Waltham, MA 02451 -
Company Description
The SOLX Glaucoma Treatment System is the next generation treatment platform that has the potential to change the current approach to glaucoma therapy. -
Website
http://www.solx.com -
Transaction Type
Venture Equity -
Transaction Amount
$3,250,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
